The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
about
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusionAnti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusionKetorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic reviewExperimental macular edema induced by macular venule occlusion in monkey.The effects of intravitreal bevacizumab in infectious and noninfectious uveitic macular edema.Etiology and treatment of the inflammatory causes of cystoid macular edema.Subclinical Macular Edema Detected by Spectral-domain Optical Coherence Tomography (SD-OCT) in HLA-B27 Positive Anterior Uveitis.Cystoid macular edema in uveitis.Control of myeloid activity during retinal inflammation.Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitusChanges in membrane conductance play a pathogenic role in osmotic glial cell swelling in detached retinasRetinal Thickening and Photoreceptor Loss in HIV Eyes without RetinitisOutcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.Hypoxia-ischemia and retinal ganglion cell damage.Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection.Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.Efficacy and vitreous levels of topical NSAIDs.Osmotic regulation of NFAT5 expression in RPE cells: The involvement of purinergic receptor signaling.The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis).The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.Cystoid macular edema.Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery.Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis ratInvolvement of A(1) adenosine receptors in osmotic volume regulation of retinal glial cells in miceIntravitreal triamcinolone for intraocular inflammation and associated macular edema.Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema.Experimental uveitis can be maintained in rabbits for a period of six weeks after a safe sensitization method.Optical coherence tomography and multifocal electroretinogram study in human immunodeficiency virus-positive children without infectious retinitis.Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
P2860
Q24194783-AF2EA402-9B32-4945-9049-A5D67B396F21Q24234625-EA195F28-B083-45C4-83B7-1DC12B25FE88Q24596891-245B5FE1-0D3D-4B51-A142-22A4BC9F05C8Q30881331-BE1C7462-5815-4E1C-A3A8-92D900362C7AQ34033983-051C7140-6E47-466A-9A33-A1E2DF69CB44Q34077613-D40DD850-9D20-4DBC-A48D-F67AFA8C0286Q35155282-1C0A8843-6BBD-4D3D-B820-042E54D71EC1Q35174894-52F035F8-8686-4DA6-9C0A-1D3F774C3BEBQ35186801-9E73EDFA-92F1-4D89-B62B-652AC694C947Q35592023-9CEBF458-C4DE-4EF9-98E5-23CA3FFE0D83Q35607463-1AB174B1-33C5-403B-AFA0-89DB6946AE6DQ35921403-C4CEC6B7-4140-490E-924F-FF31C63D0498Q36611020-616D6FF5-64F8-4D44-AAE8-6EAC208A1035Q37236104-B4944F5E-63D7-47AE-A8F0-80C030D384ADQ37684328-AA72A3CC-9A76-41E5-9016-A4E0FDB549B0Q38019465-99A28778-4073-4D48-BBAC-9DFE73BA59F3Q38546915-95135E8C-F75C-4713-A176-6CF2C52C4593Q38868241-F10F71F4-FAB9-4439-BBC6-F0996354D74DQ40539739-15A97B59-133F-4EC6-B8C0-9FB19288A48DQ40854679-E9FFD2AF-C789-4EBA-8068-7539726A5F72Q41278732-06F6B859-0BD9-4914-A94D-8D0C123DAAB7Q41317828-2CAABB98-971A-47F5-B186-74588F1DB245Q42171317-486E89AC-FAA2-4400-B4EB-D892489DF268Q42555172-D10719A4-E29F-4AEB-BA3D-1DDA9F42437FQ43096392-6BE3DDCC-72D2-4EAE-8847-06CC15774D22Q43225838-B175A986-ACD1-478E-BF02-9414269926A9Q43767421-5F2D3389-B988-4E9E-B6E8-93B455D450CFQ44436609-AF7A460B-20C4-473D-A556-55DFA26EFAB5Q44466020-6A6EC055-BF59-4C67-B052-BBBCF63D1A06Q53599525-B590860F-66B6-4800-A1A8-81C0515B70C0Q53657129-8B35DBD3-31A5-4487-B92E-62A0AC1734A6
P2860
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@ast
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@en
type
label
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@ast
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@en
prefLabel
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@ast
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@en
P356
P1476
The pathogenesis and clinical presentation of macular edema in inflammatory diseases.
@en
P2093
Guex-Crosier Y
P2888
P304
P356
10.1023/A:1002130005227
P577
1999-01-01T00:00:00Z
P6179
1022084590